Ottawa COPD Risk Score

The Ottawa COPD Risk Score estimates short‑term adverse outcomes (death, need for ventilatory support, coronary events, or early readmission) after an acute COPD exacerbation 1 [Level III evidence].

Coronary artery bypass graft history
No0Yes+1
Intervention for PVD
No0Yes+1
Intubation for respiratory distress history
No0Yes+2
HR ≥ 110/min (on arrival to ED)
No0Yes+2
Too ill to do walk test after treatment in ED
No0Yes+2
Acute ischemic changes on EKG
No0Yes+2
Pulmonary congestion on CXR
No0Yes+1
Hb < 10 g/dL (100 g/L)
No0Yes+3
Urea ≥ 12 mmol/L (BUN ≥ 34 mg/dL)
No0Yes+1
Serum CO2 ≥ 35 mEq/L (35 mmol/L)
No0Yes+1

Indications for Use

Used for adults presenting to the ED with acute COPD exacerbation to estimate 14‑day risk of adverse events (death, need for NIV/intubation, major cardiac events, or early readmission) and guide safe discharge vs observation.
Validated retrospectively with limited accuracy at low scores; higher scores (>6) show clearer risk discrimination 1 [Level II evidence].

Insights & Cautions

Identifies risk of serious short-term events after ED presentation for COPD but shows only modest discrimination (typical C‑statistics ~0.6–0.7 range, indicating limited accuracy per ESC prediction‑model standards 1 [Level III evidence]). Not validated for pre‑operative use. Often underestimates risk in severe or multimorbid COPD, and calibration varies across settings. Should not guide disposition alone—clinical assessment and spirometry remain essential.